ReviewFrontiers in oncology2024

The current landscape, advancements, and prospects in the treatment of patients with EGFR exon 20 insertion mutations warrant scientific elucidation.

Xiuyue Man et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.